Historical Stock Price
PFNX historical stock prices picture
PFNX (PFNX) has the following price history information. Looking back at PFNX historical stock prices for the last five trading days, on September 25, 2020, PFNX opened at $12.68, traded as high as $12.71 and as low as $12.66, and closed at $12.69. Trading volume was a total of 566.90K shares. On September 28, 2020, PFNX opened at $12.69, traded as high as $12.84 and as low as $12.69, and closed at $12.80. Trading volume was a total of 1.31M shares. On September 29, 2020, PFNX opened at $12.86, traded as high as $12.86 and as low as $12.73, and closed at $12.76. Trading volume was a total of 8.09M shares. On September 30, 2020, PFNX opened at $12.74, traded as high as $12.94 and as low as $12.74, and closed at $12.75. Trading volume was a total of 1.62M shares. On October 01, 2020, PFNX opened at $12.75, traded as high as $12.75 and as low as $12.75, and closed at $12.75. Trading volume was a total of 0 shares.

PFNX Historical Stock Prices By Date:

PFNX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into PFNX shares, starting with a $10,000 purchase of PFNX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/25/2014
End date: 10/01/2020
Start price/share: $5.80
End price/share: $12.75
Dividends collected/share: $0.00
Total return: 119.83%
Average Annual Total Return: 13.57%
Starting investment: $10,000.00
Ending investment: $21,987.72
Years: 6.19
Date Open High Low Close Volume
09/25/2020 $12.68 $12.71 $12.66 $12.69 566.90K
09/28/2020 $12.69 $12.84 $12.69 $12.80 1.31M
09/29/2020 $12.86 $12.86 $12.73 $12.76 8.09M
09/30/2020 $12.74 $12.94 $12.74 $12.75 1.62M
10/01/2020 $12.75 $12.75 $12.75 $12.75 0
Pfenex is a development and licensing biotechnology company focused on utilizing its proprietary protein production platform, Pfenex Expression Technology®, to develop protein therapeutics to improve existing therapies and create therapies for diseases still waiting to be addressed. The U.S. Food and Drug Administration-approved PF708 product is indicated for the treatment of osteoporosis in certain patients at high risk for fracture. Co.'s other product includes PF743 (JZP-458), which it is developing in collaboration with Jazz Pharmaceuticals Ireland Limited for the treatment of acute lymphoblastic leukemia. Co. has added PF810, a peptide based therapeutic, to its wholly owned pipeline.
Date Close
09/25/2020$12.69
09/28/2020$12.80
09/29/2020$12.76
09/30/2020$12.75
10/01/2020$12.75
PFNX is categorized under the Healthcare sector; below are some other companies in the same sector:

PGNX Historical Stock Prices
PHMD Historical Stock Prices
PIP Historical Stock Prices
PIRS Historical Stock Prices
PKI Historical Stock Prices
PLB Historical Stock Prices
PLI Historical Stock Prices
PLSE Historical Stock Prices
PLX Historical Stock Prices
PLXP Historical Stock Prices

Email EnvelopeFree PFNX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


PFNX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.